38 results on '"Hiraki, Miho"'
Search Results
2. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
3. CYTOCHROME P450 1B1 PROMOTES RENAL CELL CARCINOMA TUMORIGENESIS VIA ALTERED EXPRESSION OF CDC20 AND DAPK1 GENES: MP85-06
4. OVEREXPRESSION OF VCAN IS ASSOCIATED WITH METASTASIS AND UNFAVORABLE PROGNOSIS IN PATIENTS WITH RENAL CELL CARCINOMA: MP85-02
5. CIGARETTE SMOKING AND CYP1A1 ENHANCE PROSTATE CANCER PROGRESSION THROUGH DNA PROMOTER HYPOMETHYLATION: MP66-04
6. MP47-11 CANDIDATE BIOMARKER FOR BONE MORPHOGENETIC PROTEIN 2 PREDICTS RENAL CELL CARCINOMA PROGRESSION VIA ITS PROMOTER CPG HYPERMETHYLATION
7. MP39-16 ATTRACTIVE STRATEGY FOR TREATMENT OF ADVANCED RENAL CELL CARCINOMA BASED ON VERSICAN EXPRESSION
8. FUNCTIONAL ROLE OF BONE MORPHOGENETIC PROTEIN 2 AS TUMOR SUPPRESSOR IS INACTIVATED BY PROMOTER CPG METHYLATION IN HUMAN RENAL CELL CARCINOMA: MP23-18
9. PATHOGENESIS OF ADRENOCORTICAL TUMOR IS ASSOCIATED WITH EXTRACELLULAR ACTIVATION OF WNT SIGNALING THROUGH EPIGENETIC DYSREGULATION OF WNT INHIBITORY FACTOR-1: PD1-12
10. VERSICAN IS A PROMISING CANDIDATE BIOMARKER IN THE COMBINATION OF DOCETAXEL WITH THALIDOMIDE AS SECOND LINE CHEMOTHERAPY IN CASTRATION-RESISTANT PROSTATE CANCER AFTER DOCETAXEL RESISTANCE: 223
11. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones
12. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma
13. MP48-12 EXTRAORDINARY ELEVATION OF SERPINB2 GENE AFTER ANTI-CANCER DRUG TREATMENT IN BLADDER CANCER
14. Choroidal and Cutaneous Metastasis from Urothelial Carcinoma of the Bladder after Radical Cystectomy: A Case Report and Literature Review
15. Coordination of bone morphogenetic protein 2 (BMP2) and aberrant canonical Wnt/β-catenin signaling for heterotopic bone formation in adrenal myelolipoma: A case report
16. MP85-02 OVEREXPRESSION OF VCAN IS ASSOCIATED WITH METASTASIS AND UNFAVORABLE PROGNOSIS IN PATIENTS WITH RENAL CELL CARCINOMA
17. MP66-04 CIGARETTE SMOKING AND CYP1A1 ENHANCE PROSTATE CANCER PROGRESSION THROUGH DNA PROMOTER HYPOMETHYLATION
18. MP85-06 CYTOCHROME P450 1B1 PROMOTES RENAL CELL CARCINOMA TUMORIGENESIS VIA ALTERED EXPRESSION OF CDC20 AND DAPK1 GENES
19. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma
20. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
21. Abstract 3823: Dysregulation of bone morphogenetic protein 2 serves as a candidate molecular marker in human renal cell carcinoma
22. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
23. Versican is a potential therapeutic target in docetaxel-resistant prostate cancer
24. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor
25. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
26. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor
27. PD1-12 PATHOGENESIS OF ADRENOCORTICAL TUMOR IS ASSOCIATED WITH EXTRACELLULAR ACTIVATION OF WNT SIGNALING THROUGH EPIGENETIC DYSREGULATION OF WNT INHIBITORY FACTOR-1
28. MP23-18 FUNCTIONAL ROLE OF BONE MORPHOGENETIC PROTEIN 2 AS TUMOR SUPPRESSOR IS INACTIVATED BY PROMOTER CPG METHYLATION IN HUMAN RENAL CELL CARCINOMA
29. Overexpression of bone morphogenetic protein 2 through aberrant canonical Wnt/β-catenin signaling pathway plays an important role in heterotopic ossification of adrenal myelolipoma
30. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.
31. 223 VERSICAN IS A PROMISING CANDIDATE BIOMARKER IN THE COMBINATION OF DOCETAXEL WITH THALIDOMIDE AS SECOND LINE CHEMOTHERAPY IN CASTRATION-RESISTANT PROSTATE CANCER AFTER DOCETAXEL RESISTANCE
32. Tumor Suppressor Function of PGP9.5 Is Associated with Epigenetic Regulation in Prostate Cancer—Novel Predictor of Biochemical Recurrence after Radical Surgery
33. 1609 A NOVEL TRANSCRIPTIONAL VARIANT OF PCGEM1 PREDICTS BIOLOGICAL BEHAVIOR OF PROSTATE CANCER
34. 792 EVALUATION OF GENE EXPRESSION BY NUCLEOSTEMIN AND FAMILY MEMBERS IN BLADDER CANCER
35. 779 IGFBP-RP1 EXPRESSION IS DECREASED IN BLADDER CANCER - POSSIBLE BLADDER TUMOR SUPPRESSOR
36. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones
37. Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity.
38. Coordination of bone morphogenetic protein 2 (BMP2) and aberrant canonical Wnt/β-catenin signaling for heterotopic bone formation in adrenal myelolipoma: A case report.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.